ImmunoGenesis

Houston, TX · Founded 2019 · Privately Held (backing)

Developer of immuno-oncology therapeutics designed to create cold tumor treatments. ImmunoGenesis is based in Houston, TX and was founded in 2019. It was valued at $142 million at its later-stage round in May 2025, the last priced event on record. It has raised $67.2 million across 1 recorded round; the latest was a $44.4 million early-stage round in Mar 2024.

PMV mark · valuation
$142.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$67.2M
Last round
Early Stage VC
Mar 2024

Who backs ImmunoGenesis?

13 investors
InvestorType
Service Provider CapitalVenture capital
ADIT VenturesVenture capital
Magnetar CapitalHedge fund
PEAK6 Strategic CapitalVenture capital
3Spoke CapitalOther
BioAdvance Capital (Conshohocken)Venture capital
Reimagined VenturesFamily office
Denniston Family OfficeFamily office
Angel Physicians Fund—
Cancer Focus Fund—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ImmunoGenesis investors

13 investors are on record for ImmunoGenesis, including Service Provider Capital, ADIT Ventures, Magnetar Capital and PEAK6 Strategic Capital. By type, the record holds 4 venture capital firms, 2 family offices and 1 hedge fund. The early-stage round in Mar 2024 drew 88 investors.

Free account
More of ImmunoGenesis with a free account
  • ·The complete investor list: 13 names
  • ·Watch ImmunoGenesis: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like ImmunoGenesis. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View